ArticleArthritis research & therapy2022

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.

Till Uhlig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.